The Board of Directors of Siegfried Holding has elected COO Marcel Imwinkelried as the new CEO effective September 1, 2024.

Ligand Pharmaceuticals recently announced that it has entered into a definitive agreement to acquire Apeiron Biologics AG, which holds royalty rights to Qarziba...

Syensqo has completed the acquisition of a controlling stake in Azerys, a specialist in rosemary extraction with assets in El Jadida, Morocco.

A newly updated and automated production line is operational at AkzoNobel’s Suzhou site in China. The improvements are part of a €14 million investment to accelerate...

German chemicals, pharmaceuticals and life sciences group Merck entered a non-binding Memorandum of Understanding (MoU) with Afrigen Biologics to support the development...

Belgium-headquartered specialty materials producer Syensqo and Allozymes, a Singaporean enzyme engineering start-up, have signing of a Memorandum of Understanding (MoU)...

Bayer and Charité - Universitätsmedizin Berlin recently unveiled plans to establish the Berlin Center for Gene and Cell Therapies, a translational center for gene and...

Italian engineering group Maire Tecnimont announced that its subsidiary NextChem, which specializes in sustainable technology solutions, has been awarded a feasibility...